Line 2,355: |
Line 2,355: |
| | | | | |
| | | | | |
| + | |- |
| + | |}<br /> |
| + | |
| + | ==WHO Classification of Tumours of Breast Tumours Content== |
| + | {| class="wikitable" |
| + | |- |
| + | !'''Disease'''!!'''Page Type'''!!'''Author''' |
| + | !'''Date Assigned to Author''' |
| + | !'''Target Completion Date''' |
| + | !'''Author Content (Pending or Complete)''' |
| + | !'''Date Completed by Author'''!!'''Associate Editor''' |
| + | !'''Date of Last Editor Review''' |
| + | !'''Notes''' |
| + | |- |
| + | |'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |complete |
| + | | |
| + | |Fabiola Quintero-Rivera (FQR) |
| + | |Date page was created |
| + | | |
| + | |- |
| + | | Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease |
| + | |Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera |
| + | | |
| + | | |
| + | |complete |
| |- | | |- |
| |}<br /> | | |}<br /> |